Trial intelligence / Profile preview

Colchicine for LV Function in Anterior STEMI

NCT05200052Phase 4Completed

Sponsor
Ain Shams University
Start
Feb 2022
Primary completion
Aug 2022
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of colchicine in ST-elevation myocardial infarction (STEMI), sponsored by Ain Shams University. Started Feb 2022; status: completed.

02

Drugs

colchicine
03

Conditions

ST-elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT05200052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05200052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call